Research Articles on Tuberculosis from 1940 onwards

Impact of tigecycline versus imipenem-cilastatin on fibrinogen levels following cytoreductivesurgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC): a randomized-controlled study.
J Chemother. 2018 Jul;30(4):224-232.
Nontherapeutic equivalence of a generic product of imipenem-cilastatin is caused more by chemical instability of the active pharmaceutical ingredient (imipenem) than by its substandard amount of cilastatin.
PLoS One. 2019 Feb 6;14(2):e0211096.
Effect of Meropenem-Vaborbactam vs Piperacillin-Tazobactam on Clinical Cure or Improvement and Microbial Eradication in Complicated Urinary Tract Infection: The TANGO I Randomized Clinical Trial.
JAMA. 2018 Feb 27;319(8):788-799.
Therapeutic Drug Monitoring of Meropenem in Neonate with Necrotizing Enterocolitis: A Challenge
Training a Drug to Do New Tricks: Insights on Stability of Meropenem Administered as a Continuous Infusion.
Microbiol Insights. 2018 Oct 14;11:1178636118804549.
Imipenem-cilastatin-induced psychosis: a case report.
J Med Case Rep. 2016 Apr 27;10(1):107.
Comparison of twice a day and three times a day meropenem administration in elderly patients in a Japanese community hospital
Nagoya J Med Sci. 2018 Aug; 80(3): 391–400.
Efficacy and safety of ceftazidime-avibactam versus imipenem-cilastatin in the treatment of complicated urinary tract infections, including acute pyelonephritis, in hospitalized adults: results of a prospective, investigator-blinded, randomized study.
Curr Med Res Opin. 2012 Dec;28(12):1921-31.
Levofloxacin-amoxicillin/clavulanate-rabeprazole versus a standard seven-day triple therapy for eradication of Helicobacter pylori infection.
Biomed Res Int. 2014;2014:158520.
Proteomic identification of Axc, a novel beta-lactamase with carbapenemase activity in a meropenem-resistant clinical isolate of Achromobacter xylosoxidans.
Sci Rep. 2018 May 25;8(1):8181.